clinical-reports

Compare original and translation side by side

🇺🇸

Original

English
🇨🇳

Translation

Chinese

Clinical Report Writing

临床报告撰写

Overview

概述

Clinical report writing is the process of documenting medical information with precision, accuracy, and compliance with regulatory standards. This skill covers four major categories of clinical reports: case reports for journal publication, diagnostic reports for clinical practice, clinical trial reports for regulatory submission, and patient documentation for medical records. Apply this skill for healthcare documentation, research dissemination, and regulatory compliance.
Critical Principle: Clinical reports must be accurate, complete, objective, and compliant with applicable regulations (HIPAA, FDA, ICH-GCP). Patient privacy and data integrity are paramount. All clinical documentation must support evidence-based decision-making and meet professional standards.
临床报告撰写是指精准、准确地记录医疗信息,并符合监管标准的过程。本技能涵盖四大类临床报告:用于期刊发表的病例报告、临床实践中的诊断报告、用于监管申报的临床试验报告,以及用于医疗记录的患者文档。可将本技能应用于医疗保健文档记录、研究成果传播和合规性保障。
**核心原则:临床报告必须准确、完整、客观,并符合适用法规(HIPAA、FDA、ICH-GCP)。**患者隐私和数据完整性至关重要。所有临床文档必须支持循证决策,并符合专业标准。

When to Use This Skill

何时使用本技能

This skill should be used when:
  • Writing clinical case reports for journal submission (CARE guidelines)
  • Creating diagnostic reports (radiology, pathology, laboratory)
  • Documenting clinical trial data and adverse events
  • Preparing clinical study reports (CSR) for regulatory submission
  • Writing patient progress notes, SOAP notes, and clinical summaries
  • Drafting discharge summaries, H&P documents, or consultation notes
  • Ensuring HIPAA compliance and proper de-identification
  • Validating clinical documentation for completeness and accuracy
  • Preparing serious adverse event (SAE) reports
  • Creating data safety monitoring board (DSMB) reports
在以下场景中应使用本技能:
  • 撰写用于期刊投稿的临床病例报告(遵循CARE指南)
  • 创建诊断报告(放射、病理、实验室)
  • 记录临床试验数据和不良事件
  • 准备用于监管申报的临床研究报告(CSR)
  • 撰写患者病程记录、SOAP记录和临床小结
  • 起草出院小结、H&P文档或会诊记录
  • 确保HIPAA合规性和正确去标识化
  • 验证临床文档的完整性和准确性
  • 准备严重不良事件(SAE)报告
  • 创建数据安全监查委员会(DSMB)报告

Visual Enhancement with Scientific Schematics

利用科学示意图优化可视化效果

⚠️ MANDATORY: Every clinical report MUST include at least 1 AI-generated figure using the scientific-schematics skill.
This is not optional. Clinical reports benefit greatly from visual elements. Before finalizing any document:
  1. Generate at minimum ONE schematic or diagram (e.g., patient timeline, diagnostic algorithm, or treatment workflow)
  2. For case reports: include clinical progression timeline
  3. For trial reports: include CONSORT flow diagram
How to generate figures:
  • Use the scientific-schematics skill to generate AI-powered publication-quality diagrams
  • Simply describe your desired diagram in natural language
  • Nano Banana Pro will automatically generate, review, and refine the schematic
How to generate schematics:
bash
python scripts/generate_schematic.py "your diagram description" -o figures/output.png
The AI will automatically:
  • Create publication-quality images with proper formatting
  • Review and refine through multiple iterations
  • Ensure accessibility (colorblind-friendly, high contrast)
  • Save outputs in the figures/ directory
When to add schematics:
  • Patient case timelines and clinical progression diagrams
  • Diagnostic algorithm flowcharts
  • Treatment protocol workflows
  • Anatomical diagrams for case reports
  • Clinical trial participant flow diagrams (CONSORT)
  • Adverse event classification trees
  • Any complex concept that benefits from visualization
For detailed guidance on creating schematics, refer to the scientific-schematics skill documentation.

⚠️ 强制性要求:每份临床报告必须至少包含1张使用scientific-schematics技能生成的AI图。
此要求为硬性规定。临床报告可从视觉元素中大幅获益。在最终确定任何文档前:
  1. 至少生成1张示意图或图表(例如:患者时间线、诊断算法或治疗流程)
  2. 对于病例报告:需包含临床进展时间线
  3. 对于试验报告:需包含CONSORT流程图
如何生成图:
  • 使用scientific-schematics技能生成符合出版质量的AI驱动图表
  • 只需用自然语言描述你想要的图表
  • Nano Banana Pro将自动生成、审核并优化示意图
如何生成示意图:
bash
python scripts/generate_schematic.py "your diagram description" -o figures/output.png
AI将自动:
  • 创建格式规范的出版级图像
  • 通过多次迭代进行审核和优化
  • 确保可访问性(色盲友好、高对比度)
  • 将输出保存到figures/目录
何时添加示意图:
  • 患者病例时间线和临床进展图
  • 诊断算法流程图
  • 治疗方案工作流
  • 病例报告中的解剖图
  • 临床试验受试者流程图(CONSORT)
  • 不良事件分类树
  • 任何需要可视化的复杂概念
有关创建示意图的详细指南,请参考scientific-schematics技能文档。

Core Capabilities

核心能力

1. Clinical Case Reports for Journal Publication

1. 用于期刊发表的临床病例报告

Clinical case reports describe unusual clinical presentations, novel diagnoses, or rare complications. They contribute to medical knowledge and are published in peer-reviewed journals.
临床病例报告描述罕见的临床表现、新诊断或罕见并发症。它们为医学知识做出贡献,并发表在同行评审期刊上。

CARE Guidelines Compliance

遵循CARE指南

The CARE (CAse REport) guidelines provide a standardized framework for case report writing. All case reports should follow this checklist:
Title
  • Include the words "case report" or "case study"
  • Indicate the area of focus
  • Example: "Unusual Presentation of Acute Myocardial Infarction in a Young Patient: A Case Report"
Keywords
  • 2-5 keywords for indexing and searchability
  • Use MeSH (Medical Subject Headings) terms when possible
Abstract (structured or unstructured, 150-250 words)
  • Introduction: What is unique or novel about the case?
  • Patient concerns: Primary symptoms and key medical history
  • Diagnoses: Primary and secondary diagnoses
  • Interventions: Key treatments and procedures
  • Outcomes: Clinical outcome and follow-up
  • Conclusions: Main takeaway or clinical lesson
Introduction
  • Brief background on the medical condition
  • Why this case is novel or important
  • Literature review of similar cases (brief)
  • What makes this case worth reporting
Patient Information
  • Demographics (age, sex, race/ethnicity if relevant)
  • Medical history, family history, social history
  • Relevant comorbidities
  • De-identification: Remove or alter 18 HIPAA identifiers
  • Patient consent: Document informed consent for publication
Clinical Findings
  • Chief complaint and presenting symptoms
  • Physical examination findings
  • Timeline of symptoms (consider timeline figure or table)
  • Relevant clinical observations
Timeline
  • Chronological summary of key events
  • Dates of symptoms, diagnosis, interventions, outcomes
  • Can be presented as a table or figure
  • Example format:
    • Day 0: Initial presentation with symptoms X, Y, Z
    • Day 2: Diagnostic test A performed, revealed finding B
    • Day 5: Treatment initiated with drug C
    • Day 14: Clinical improvement noted
    • Month 3: Follow-up examination shows complete resolution
Diagnostic Assessment
  • Diagnostic tests performed (labs, imaging, procedures)
  • Results and interpretation
  • Differential diagnosis considered
  • Rationale for final diagnosis
  • Challenges in diagnosis
Therapeutic Interventions
  • Medications (names, dosages, routes, duration)
  • Procedures or surgeries performed
  • Non-pharmacological interventions
  • Reasoning for treatment choices
  • Alternative treatments considered
Follow-up and Outcomes
  • Clinical outcome (resolution, improvement, unchanged, worsened)
  • Follow-up duration and frequency
  • Long-term outcomes if available
  • Patient-reported outcomes
  • Adherence to treatment
Discussion
  • Strengths and novelty of the case
  • How this case compares to existing literature
  • Limitations of the case report
  • Potential mechanisms or explanations
  • Clinical implications and lessons learned
  • Unanswered questions or areas for future research
Patient Perspective (optional but encouraged)
  • Patient's experience and viewpoint
  • Impact on quality of life
  • Patient-reported outcomes
  • Quote from patient if appropriate
Informed Consent
  • Statement documenting patient consent for publication
  • If patient deceased or unable to consent, describe proxy consent
  • For pediatric cases, parental/guardian consent
  • Example: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal."
For detailed CARE guidelines, refer to
references/case_report_guidelines.md
.
CARE(病例报告)指南为病例报告撰写提供了标准化框架。所有病例报告均应遵循以下清单:
标题
  • 包含“病例报告”或“病例研究”字样
  • 指明重点领域
  • 示例:“年轻患者急性心肌梗死的罕见表现:1例病例报告”
关键词
  • 2-5个用于索引和检索的关键词
  • 尽可能使用MeSH(医学主题词)术语
摘要(结构化或非结构化,150-250词)
  • 引言:该病例的独特或新颖之处是什么?
  • 患者主诉:主要症状和关键病史
  • 诊断:主要和次要诊断
  • 干预:关键治疗和操作
  • 结局:临床结局和随访
  • 结论:主要收获或临床经验
引言
  • 对该疾病的简要背景介绍
  • 该病例为何具有新颖性或重要性
  • 类似病例的文献综述(简要)
  • 该病例值得报告的原因
患者信息
  • 人口统计学信息(年龄、性别、种族/民族,如相关)
  • 病史、家族史、社会史
  • 相关合并症
  • 去标识化:移除或修改18项HIPAA标识符
  • 患者知情同意:记录用于发表的知情同意
临床发现
  • 主诉和现病史
  • 体格检查结果
  • 症状时间线(可考虑使用时间线图或表格)
  • 相关临床观察
时间线
  • 关键事件的 chronological 摘要
  • 症状、诊断、干预、结局的日期
  • 可采用表格或图的形式呈现
  • 示例格式:
    • 第0天:首次出现症状X、Y、Z
    • 第2天:完成诊断检查A,发现结果B
    • 第5天:启动药物C治疗
    • 第14天:观察到临床改善
    • 第3个月:随访检查显示完全缓解
诊断评估
  • 完成的诊断检查(实验室、影像、操作)
  • 结果和解读
  • 考虑的鉴别诊断
  • 最终诊断的依据
  • 诊断中的挑战
治疗干预
  • 药物(名称、剂量、途径、疗程)
  • 完成的操作或手术
  • 非药物干预
  • 治疗选择的依据
  • 考虑过的替代治疗
随访与结局
  • 临床结局(缓解、改善、无变化、恶化)
  • 随访时长和频率
  • 如可获得,提供长期结局
  • 患者报告结局
  • 治疗依从性
讨论
  • 该病例的优势和新颖性
  • 该病例与现有文献的对比
  • 病例报告的局限性
  • 潜在机制或解释
  • 临床意义和经验教训
  • 未解决的问题或未来研究方向
患者视角(可选但推荐)
  • 患者的经历和观点
  • 对生活质量的影响
  • 患者报告结局
  • 如合适,引用患者原话
知情同意
  • 记录患者同意发表的声明
  • 如患者已故或无法同意,说明代理同意情况
  • 对于儿科病例,需父母/监护人同意
  • 示例:“已获得患者的书面知情同意,同意发表本病例报告及附带影像。书面同意书副本可供本刊主编查阅。”
有关详细的CARE指南,请参考
references/case_report_guidelines.md

Journal-Specific Requirements

期刊特定要求

Different journals have specific formatting requirements:
  • Word count limits (typically 1500-3000 words)
  • Number of figures/tables allowed
  • Reference style (AMA, Vancouver, APA)
  • Structured vs. unstructured abstract
  • Supplementary materials policies
Check journal instructions for authors before submission.
不同期刊有特定的格式要求:
  • 字数限制(通常1500-3000词)
  • 允许的图/表数量
  • 参考文献格式(AMA、温哥华、APA)
  • 结构化与非结构化摘要
  • 补充材料政策
投稿前请查阅期刊的作者须知。

De-identification and Privacy

去标识化与隐私

18 HIPAA Identifiers to Remove or Alter:
  1. Names
  2. Geographic subdivisions smaller than state
  3. Dates (except year)
  4. Telephone numbers
  5. Fax numbers
  6. Email addresses
  7. Social Security numbers
  8. Medical record numbers
  9. Health plan beneficiary numbers
  10. Account numbers
  11. Certificate/license numbers
  12. Vehicle identifiers and serial numbers
  13. Device identifiers and serial numbers
  14. Web URLs
  15. IP addresses
  16. Biometric identifiers
  17. Full-face photographs
  18. Any other unique identifying characteristic
Best Practices:
  • Use "the patient" instead of names
  • Report age ranges (e.g., "a woman in her 60s") or exact age if relevant
  • Use approximate dates or time intervals (e.g., "3 months prior")
  • Remove institution names unless necessary
  • Blur or crop identifying features in images
  • Obtain explicit consent for any potentially identifying information
需移除或修改的18项HIPAA标识符:
  1. 姓名
  2. 小于州级的地理细分
  3. 日期(年份除外)
  4. 电话号码
  5. 传真号码
  6. 电子邮件地址
  7. 社会保障号码
  8. 病历号
  9. 健康计划受益人编号
  10. 账户编号
  11. 证书/执照编号
  12. 车辆标识符和序列号
  13. 设备标识符和序列号
  14. 网页URL
  15. IP地址
  16. 生物识别标识符
  17. 正面照片
  18. 任何其他唯一识别特征
最佳实践:
  • 使用“患者”代替姓名
  • 报告年龄范围(例如:“一名60多岁的女性”),如相关可使用确切年龄
  • 使用近似日期或时间间隔(例如:“3个月前”)
  • 除非必要,移除机构名称
  • 模糊或裁剪影像中的识别特征
  • 对于任何可能的识别信息,获取明确同意

2. Clinical Diagnostic Reports

2. 临床诊断报告

Diagnostic reports communicate findings from imaging studies, pathological examinations, and laboratory tests. They must be clear, accurate, and actionable.
诊断报告传达影像检查、病理检查和实验室检验的结果。报告必须清晰、准确且具备可操作性。

Radiology Reports

放射报告

Radiology reports follow a standardized structure to ensure clarity and completeness.
Standard Structure:
1. Patient Demographics
  • Patient name (or ID in research contexts)
  • Date of birth or age
  • Medical record number
  • Examination date and time
2. Clinical Indication
  • Reason for examination
  • Relevant clinical history
  • Specific clinical question to be answered
  • Example: "Rule out pulmonary embolism in patient with acute dyspnea"
3. Technique
  • Imaging modality (X-ray, CT, MRI, ultrasound, PET, etc.)
  • Anatomical region examined
  • Contrast administration (type, route, volume)
  • Protocol or sequence used
  • Technical quality and limitations
  • Example: "Contrast-enhanced CT of the chest, abdomen, and pelvis was performed using 100 mL of intravenous iodinated contrast. Oral contrast was not administered."
4. Comparison
  • Prior imaging studies available for comparison
  • Dates of prior studies
  • Stability or change from prior imaging
  • Example: "Comparison: CT chest from [date]"
5. Findings
  • Systematic description of imaging findings
  • Organ-by-organ or region-by-region approach
  • Positive findings first, then pertinent negatives
  • Measurements of lesions or abnormalities
  • Use of standardized terminology (ACR lexicon, RadLex)
  • Example:
    • Lungs: Bilateral ground-glass opacities, predominant in the lower lobes. No consolidation or pleural effusion.
    • Mediastinum: No lymphadenopathy. Heart size normal.
    • Abdomen: Liver, spleen, pancreas unremarkable. No free fluid.
6. Impression/Conclusion
  • Concise summary of key findings
  • Answers to the clinical question
  • Differential diagnosis if applicable
  • Recommendations for follow-up or additional studies
  • Level of suspicion or diagnostic certainty
  • Example:
    • "1. Bilateral ground-glass opacities consistent with viral pneumonia or atypical infection. COVID-19 cannot be excluded. Clinical correlation recommended.
      1. No evidence of pulmonary embolism.
      1. Recommend follow-up imaging in 4-6 weeks to assess resolution."
Structured Reporting:
Many radiology departments use structured reporting templates for common examinations:
  • Lung nodule reporting (Lung-RADS)
  • Breast imaging (BI-RADS)
  • Liver imaging (LI-RADS)
  • Prostate imaging (PI-RADS)
  • CT colonography (C-RADS)
Structured reports improve consistency, reduce ambiguity, and facilitate data extraction.
For radiology reporting standards, see
references/diagnostic_reports_standards.md
.
放射报告遵循标准化结构,以确保清晰和完整。
标准结构:
1. 患者人口统计学信息
  • 患者姓名(或研究场景中的ID)
  • 出生日期或年龄
  • 病历号
  • 检查日期和时间
2. 临床指征
  • 检查原因
  • 相关病史
  • 需解答的特定临床问题
  • 示例:“排查急性呼吸困难患者的肺栓塞”
3. 检查技术
  • 影像模态(X线、CT、MRI、超声、PET等)
  • 检查的解剖部位
  • 对比剂使用(类型、途径、剂量)
  • 使用的协议或序列
  • 技术质量和局限性
  • 示例:“胸部、腹部和盆腔增强CT检查,使用100mL静脉碘对比剂。未使用口服对比剂。”
4. 对比
  • 可用于对比的既往影像检查
  • 既往检查的日期
  • 与既往影像相比的稳定性或变化
  • 示例:“对比:[日期]的胸部CT”
5. 发现
  • 影像发现的系统性描述
  • 按器官或部位的描述方式
  • 先描述阳性发现,再描述相关阴性发现
  • 病变或异常的测量值
  • 使用标准化术语(ACR术语表、RadLex)
  • 示例:
    • 肺部:双肺磨玻璃影,以双下肺为主。无实变或胸腔积液。
    • 纵隔:无淋巴结肿大。心脏大小正常。
    • 腹部:肝、脾、胰腺未见异常。无游离液体。
6. 印象/结论
  • 关键发现的简明摘要
  • 临床问题的解答
  • 如适用,列出鉴别诊断
  • 随访或进一步检查的建议
  • 可疑程度或诊断确定性
  • 示例:
    • “1. 双肺磨玻璃影符合病毒性肺炎或非典型感染。不能排除COVID-19。建议结合临床。
      1. 无肺栓塞证据。
      1. 建议4-6周后随访影像以评估吸收情况。”
结构化报告:
许多放射科对常见检查使用结构化报告模板:
  • 肺结节报告(Lung-RADS)
  • 乳腺影像(BI-RADS)
  • 肝脏影像(LI-RADS)
  • 前列腺影像(PI-RADS)
  • CT结肠成像(C-RADS)
结构化报告可提高一致性、减少歧义,并便于数据提取。
有关放射报告标准,请参阅
references/diagnostic_reports_standards.md

Pathology Reports

病理报告

Pathology reports document microscopic findings from tissue specimens and provide diagnostic conclusions.
Surgical Pathology Report Structure:
1. Patient Information
  • Patient name and identifiers
  • Date of birth, age, sex
  • Ordering physician
  • Medical record number
  • Specimen received date
2. Specimen Information
  • Specimen type (biopsy, excision, resection)
  • Anatomical site
  • Laterality if applicable
  • Number of specimens/blocks/slides
  • Example: "Skin, left forearm, excisional biopsy"
3. Clinical History
  • Relevant clinical information
  • Indication for biopsy
  • Prior diagnoses
  • Example: "History of melanoma. New pigmented lesion, rule out recurrence."
4. Gross Description
  • Macroscopic appearance of specimen
  • Size, weight, color, consistency
  • Orientation markers if present
  • Sectioning and sampling approach
  • Example: "The specimen consists of an ellipse of skin measuring 2.5 x 1.0 x 0.5 cm. A pigmented lesion measuring 0.6 cm in diameter is present on the surface. The specimen is serially sectioned and entirely submitted in cassettes A1-A3."
5. Microscopic Description
  • Histological findings
  • Cellular characteristics
  • Architectural patterns
  • Presence of malignancy
  • Margins if applicable
  • Special stains or immunohistochemistry results
6. Diagnosis
  • Primary diagnosis
  • Grade and stage if applicable (cancer)
  • Margin status
  • Lymph node status if applicable
  • Synoptic reporting for cancers (CAP protocols)
  • Example:
    • "MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE
    • Breslow thickness: 1.2 mm
    • Clark level: IV
    • Mitotic rate: 3/mm²
    • Ulceration: Absent
    • Margins: Negative (closest margin 0.4 cm)
    • Lymphovascular invasion: Not identified"
7. Comment (if needed)
  • Additional context or interpretation
  • Differential diagnosis
  • Recommendations for additional studies
  • Clinical correlation suggestions
Synoptic Reporting:
The College of American Pathologists (CAP) provides synoptic reporting templates for cancer specimens. These checklists ensure all relevant diagnostic elements are documented.
Key elements for cancer reporting:
  • Tumor site
  • Tumor size
  • Histologic type
  • Histologic grade
  • Extent of invasion
  • Lymph-vascular invasion
  • Perineural invasion
  • Margins
  • Lymph nodes (number examined, number positive)
  • Pathologic stage (TNM classification)
  • Ancillary studies (molecular markers, biomarkers)
病理报告记录组织标本的显微镜下发现,并提供诊断结论。
外科病理报告结构:
1. 患者信息
  • 患者姓名和标识符
  • 出生日期、年龄、性别
  • 申请医师
  • 病历号
  • 标本接收日期
2. 标本信息
  • 标本类型(活检、切除、根治性切除)
  • 解剖部位
  • 如适用,标注左右侧
  • 标本/蜡块/切片数量
  • 示例:“左前臂皮肤,切除活检”
3. 病史
  • 相关临床信息
  • 活检指征
  • 既往诊断
  • 示例:“黑色素瘤病史。新发色素性病变,排查复发。”
4. 大体描述
  • 标本的肉眼外观
  • 大小、重量、颜色、质地
  • 如存在,标注定位标记
  • 取材和切片方式
  • 示例:“标本为一椭圆形皮肤组织,大小2.5×1.0×0.5cm。表面可见一0.6cm直径的色素性病变。标本连续切片,全部置于A1-A3号蜡块中。”
5. 显微镜下描述
  • 组织学发现
  • 细胞特征
  • 结构模式
  • 是否存在恶性病变
  • 如适用,切缘情况
  • 特殊染色或免疫组化结果
6. 诊断
  • 主要诊断
  • 如为癌症,标注分级和分期
  • 切缘情况
  • 如适用,淋巴结情况
  • 癌症的概要报告(CAP协议)
  • 示例:
    • “恶性黑色素瘤,浅表扩散型
    • Breslow厚度:1.2mm
    • Clark分级:IV级
    • 有丝分裂率:3/mm²
    • 溃疡:无
    • 切缘:阴性(最近切缘0.4cm)
    • 脉管侵犯:未查见”
7. 注释(如需要)
  • 额外背景或解读
  • 鉴别诊断
  • 进一步检查的建议
  • 结合临床的建议
概要报告:
美国病理学家学院(CAP)为癌症标本提供概要报告模板。这些清单确保记录所有相关诊断要素。
癌症报告的关键要素:
  • 肿瘤部位
  • 肿瘤大小
  • 组织学类型
  • 组织学分级
  • 侵犯范围
  • 脉管侵犯
  • 神经周围侵犯
  • 切缘
  • 淋巴结(检查数量、阳性数量)
  • 病理分期(TNM分类)
  • 辅助检查(分子标记物、生物标志物)

Laboratory Reports

实验室报告

Laboratory reports communicate test results for clinical specimens (blood, urine, tissue, etc.).
Standard Components:
1. Patient and Specimen Information
  • Patient identifiers
  • Specimen type (blood, serum, urine, CSF, etc.)
  • Collection date and time
  • Received date and time
  • Ordering provider
2. Test Name and Method
  • Full test name
  • Methodology (immunoassay, spectrophotometry, PCR, etc.)
  • Laboratory accession number
3. Results
  • Quantitative or qualitative result
  • Units of measurement
  • Reference range (normal values)
  • Flags for abnormal values (H = high, L = low)
  • Critical values highlighted
  • Example:
    • Hemoglobin: 8.5 g/dL (L) [Reference: 12.0-16.0 g/dL]
    • White Blood Cell Count: 15.2 x10³/μL (H) [Reference: 4.5-11.0 x10³/μL]
4. Interpretation (when applicable)
  • Clinical significance of results
  • Suggested follow-up or additional testing
  • Correlation with diagnosis
  • Drug levels and therapeutic ranges
5. Quality Control Information
  • Specimen adequacy
  • Specimen quality issues (hemolyzed, lipemic, clotted)
  • Delays in processing
  • Technical limitations
Critical Value Reporting:
  • Life-threatening results require immediate notification
  • Examples: glucose <40 or >500 mg/dL, potassium <2.5 or >6.5 mEq/L
  • Document notification time and recipient
For laboratory standards and terminology, see
references/diagnostic_reports_standards.md
.
实验室报告传达临床标本(血液、尿液、组织等)的检验结果。
标准组成部分:
1. 患者和标本信息
  • 患者标识符
  • 标本类型(血液、血清、尿液、脑脊液等)
  • 采集日期和时间
  • 接收日期和时间
  • 申请医师
2. 检验名称和方法
  • 完整检验名称
  • 检测方法(免疫分析、分光光度法、PCR等)
  • 实验室编号
3. 结果
  • 定量或定性结果
  • 计量单位
  • 参考范围(正常值)
  • 异常结果标记(H=高,L=低)
  • 危急值高亮显示
  • 示例:
    • 血红蛋白:8.5g/dL(L)[参考值:12.0-16.0g/dL]
    • 白细胞计数:15.2×10³/μL(H)[参考值:4.5-11.0×10³/μL]
4. 解读(如适用)
  • 结果的临床意义
  • 建议的随访或进一步检查
  • 与诊断的关联
  • 药物浓度和治疗范围
5. 质量控制信息
  • 标本充分性
  • 标本质量问题(溶血、脂血、凝固)
  • 处理延迟
  • 技术局限性
危急值报告:
  • 危及生命的结果需立即通知
  • 示例:血糖<40或>500mg/dL,钾<2.5或>6.5mEq/L
  • 记录通知时间和接收人
有关实验室标准和术语,请参阅
references/diagnostic_reports_standards.md

3. Clinical Trial Reports

3. 临床试验报告

Clinical trial reports document the conduct, results, and safety of clinical research studies. These reports are essential for regulatory submissions and scientific publication.
临床试验报告记录临床研究的实施、结果和安全性。这些报告对于监管申报和科学发表至关重要。

Serious Adverse Event (SAE) Reports

严重不良事件(SAE)报告

SAE reports document unexpected serious adverse reactions during clinical trials. Regulatory requirements mandate timely reporting to IRBs, sponsors, and regulatory agencies.
Definition of Serious Adverse Event: An adverse event is serious if it:
  • Results in death
  • Is life-threatening
  • Requires inpatient hospitalization or prolongation of existing hospitalization
  • Results in persistent or significant disability/incapacity
  • Is a congenital anomaly/birth defect
  • Requires intervention to prevent permanent impairment or damage
SAE Report Components:
1. Study Information
  • Protocol number and title
  • Study phase
  • Sponsor name
  • Principal investigator
  • IND/IDE number (if applicable)
  • Clinical trial registry number (NCT number)
2. Patient Information (De-identified)
  • Subject ID or randomization number
  • Age, sex, race/ethnicity
  • Study arm or treatment group
  • Date of informed consent
  • Date of first study intervention
3. Event Information
  • Event description (narrative)
  • Date of onset
  • Date of resolution (or ongoing)
  • Severity (mild, moderate, severe)
  • Seriousness criteria met
  • Outcome (recovered, recovering, not recovered, fatal, unknown)
4. Causality Assessment
  • Relationship to study intervention (unrelated, unlikely, possible, probable, definite)
  • Relationship to study procedures
  • Relationship to underlying disease
  • Rationale for causality determination
5. Action Taken
  • Modification of study intervention (dose reduction, temporary hold, permanent discontinuation)
  • Concomitant medications or treatments administered
  • Hospitalization details
  • Outcome and follow-up plan
6. Expectedness
  • Expected per protocol or investigator's brochure
  • Unexpected event requiring expedited reporting
  • Comparison to known safety profile
7. Narrative
  • Detailed description of the event
  • Timeline of events
  • Clinical course and management
  • Laboratory and diagnostic test results
  • Final diagnosis or conclusion
8. Reporter Information
  • Name and contact of reporter
  • Report date
  • Signature
Regulatory Timelines:
  • Fatal or life-threatening unexpected SAEs: 7 days for preliminary report, 15 days for complete report
  • Other serious unexpected events: 15 days
  • IRB notification: per institutional policy, typically within 5-10 days
For detailed SAE reporting guidance, see
references/clinical_trial_reporting.md
.
SAE报告记录临床试验期间发生的意外严重不良反应。监管要求规定需及时向IRB、申办方和监管机构报告。
严重不良事件的定义: 如不良事件符合以下任一情况,则视为严重:
  • 导致死亡
  • 危及生命
  • 需要住院治疗或延长现有住院时间
  • 导致持续或显著的残疾/失能
  • 为先天异常/出生缺陷
  • 需要干预以防止永久性损伤或损害
SAE报告组成部分:
1. 研究信息
  • 方案编号和标题
  • 研究阶段
  • 申办方名称
  • 主要研究者
  • IND/IDE编号(如适用)
  • 临床试验注册编号(NCT编号)
2. 患者信息(去标识化)
  • 受试者ID或随机编号
  • 年龄、性别、种族/民族
  • 研究组或治疗组
  • 知情同意日期
  • 首次研究干预日期
3. 事件信息
  • 事件描述(叙述性)
  • 发病日期
  • 缓解日期(或持续中)
  • 严重程度(轻度、中度、重度)
  • 符合的严重性标准
  • 结局(恢复、恢复中、未恢复、死亡、未知)
4. 因果关系评估
  • 与研究干预的相关性(无关、不太可能、可能、很可能、确定)
  • 与研究操作的相关性
  • 与基础疾病的相关性
  • 因果关系判定的依据
5. 采取的措施
  • 研究干预的调整(剂量减少、临时暂停、永久终止)
  • 合并用药或治疗
  • 住院详情
  • 结局和随访计划
6. 预期性
  • 方案或研究者手册中是否预期发生
  • 需快速报告的意外事件
  • 与已知安全性特征的对比
7. 叙述
  • 事件的详细描述
  • 事件时间线
  • 临床过程和处理
  • 实验室和诊断检查结果
  • 最终诊断或结论
8. 报告人信息
  • 报告人姓名和联系方式
  • 报告日期
  • 签名
监管时间线:
  • 致命或危及生命的意外SAE:7天内提交初步报告,15天内提交完整报告
  • 其他严重意外事件:15天内提交
  • IRB通知:根据机构政策,通常5-10天内
有关SAE报告的详细指南,请参阅
references/clinical_trial_reporting.md

Clinical Study Reports (CSR)

临床研究报告(CSR)

Clinical study reports are comprehensive documents summarizing the design, conduct, and results of clinical trials. They are submitted to regulatory agencies as part of drug approval applications.
ICH-E3 Structure:
The ICH E3 guideline defines the structure and content of clinical study reports.
Main Sections:
1. Title Page
  • Study title and protocol number
  • Sponsor and investigator information
  • Report date and version
2. Synopsis (5-15 pages)
  • Brief summary of entire study
  • Objectives, methods, results, conclusions
  • Key efficacy and safety findings
  • Can stand alone
3. Table of Contents
4. List of Abbreviations and Definitions
5. Ethics (Section 2)
  • IRB/IEC approvals
  • Informed consent process
  • GCP compliance statement
6. Investigators and Study Administrative Structure (Section 3)
  • List of investigators and sites
  • Study organization
  • Monitoring and quality assurance
7. Introduction (Section 4)
  • Background and rationale
  • Study objectives and purpose
8. Study Objectives and Plan (Section 5)
  • Overall design and plan
  • Objectives (primary and secondary)
  • Endpoints (efficacy and safety)
  • Sample size determination
9. Study Patients (Section 6)
  • Inclusion and exclusion criteria
  • Patient disposition
  • Protocol deviations
  • Demographic and baseline characteristics
10. Efficacy Evaluation (Section 7)
  • Data sets analyzed (ITT, PP, safety)
  • Demographic and other baseline characteristics
  • Efficacy results for primary and secondary endpoints
  • Subgroup analyses
  • Dropouts and missing data
11. Safety Evaluation (Section 8)
  • Extent of exposure
  • Adverse events (summary tables)
  • Serious adverse events (narratives)
  • Laboratory values
  • Vital signs and physical findings
  • Deaths and other serious events
12. Discussion and Overall Conclusions (Section 9)
  • Interpretation of results
  • Benefit-risk assessment
  • Clinical implications
13. Tables, Figures, and Graphs (Section 10)
14. Reference List (Section 11)
15. Appendices (Section 12)
  • Study protocol and amendments
  • Sample case report forms
  • List of investigators and ethics committees
  • Patient information and consent forms
  • Investigator's brochure references
  • Publications based on the study
Key Principles:
  • Objectivity and transparency
  • Comprehensive data presentation
  • Adherence to statistical analysis plan
  • Clear presentation of safety data
  • Integration of appendices
For ICH-E3 templates and detailed guidance, see
references/clinical_trial_reporting.md
and
assets/clinical_trial_csr_template.md
.
临床研究报告是总结临床试验设计、实施和结果的综合性文档。它们作为药物批准申请的一部分提交给监管机构。
ICH-E3结构:
ICH E3指南定义了临床研究报告的结构和内容。
主要章节:
1. 标题页
  • 研究标题和方案编号
  • 申办方和研究者信息
  • 报告日期和版本
2. 概要(5-15页)
  • 整个研究的简要总结
  • 目的、方法、结果、结论
  • 关键疗效和安全性发现
  • 可独立存在
3. 目录
4. 缩写和定义列表
5. 伦理(第2节)
  • IRB/IEC批准
  • 知情同意流程
  • GCP合规声明
6. 研究者和研究管理结构(第3节)
  • 研究者和研究中心列表
  • 研究组织
  • 监查和质量保证
7. 引言(第4节)
  • 背景和依据
  • 研究目的和目标
8. 研究目的和计划(第5节)
  • 整体设计和计划
  • 目的(主要和次要)
  • 终点(疗效和安全性)
  • 样本量确定
9. 研究患者(第6节)
  • 纳入和排除标准
  • 患者处置
  • 方案偏离
  • 人口统计学和基线特征
10. 疗效评估(第7节)
  • 分析数据集(ITT、PP、安全性)
  • 人口统计学和其他基线特征
  • 主要和次要终点的疗效结果
  • 亚组分析
  • 脱落和缺失数据
11. 安全性评估(第8节)
  • 暴露程度
  • 不良事件(汇总表)
  • 严重不良事件(叙述性)
  • 实验室值
  • 生命体征和体格检查结果
  • 死亡和其他严重事件
12. 讨论和总体结论(第9节)
  • 结果解读
  • 获益-风险评估
  • 临床意义
13. 表格、图和图表(第10节)
14. 参考文献列表(第11节)
15. 附录(第12节)
  • 研究方案和修正案
  • 病例报告表样本
  • 研究者和伦理委员会列表
  • 患者信息和知情同意书
  • 研究者手册参考文献
  • 基于该研究的出版物
核心原则:
  • 客观性和透明度
  • 全面的数据呈现
  • 遵循统计分析计划
  • 清晰呈现安全性数据
  • 附录整合
有关ICH-E3模板和详细指南,请参阅
references/clinical_trial_reporting.md
assets/clinical_trial_csr_template.md

Protocol Deviations

方案偏离

Protocol deviations are departures from the approved study protocol. They must be documented, assessed, and reported.
Categories:
  • Minor deviation: Does not significantly impact patient safety or data integrity
  • Major deviation: May impact patient safety, data integrity, or study conduct
  • Violation: Serious deviation requiring immediate action and reporting
Documentation Requirements:
  • Description of deviation
  • Date of occurrence
  • Subject ID affected
  • Impact on safety and data
  • Corrective and preventive actions (CAPA)
  • Root cause analysis
  • Preventive measures implemented
方案偏离是指偏离已批准的研究方案的情况。必须对其进行记录、评估和报告。
分类:
  • 轻微偏离:对患者安全性或数据完整性无显著影响
  • 重大偏离:可能影响患者安全性、数据完整性或研究实施
  • 违规:严重偏离,需立即采取行动并报告
记录要求:
  • 偏离描述
  • 发生日期
  • 受影响的受试者ID
  • 对安全性和数据的影响
  • 纠正和预防措施(CAPA)
  • 根本原因分析
  • 实施的预防措施

4. Patient Clinical Documentation

4. 患者临床文档

Patient documentation records clinical encounters, progress, and care plans. Accurate documentation supports continuity of care, billing, and legal protection.
患者文档记录临床诊疗、病情进展和护理计划。准确的文档支持护理连续性、计费和法律保护。

SOAP Notes

SOAP记录

SOAP notes are the most common format for progress notes in clinical practice.
Structure:
S - Subjective
  • Patient's reported symptoms and concerns
  • History of present illness (HPI)
  • Review of systems (ROS) relevant to visit
  • Patient's own words (use quotes when helpful)
  • Example: "Patient reports worsening shortness of breath over the past 3 days, particularly with exertion. Denies chest pain, fever, or cough."
O - Objective
  • Measurable clinical findings
  • Vital signs (temperature, blood pressure, heart rate, respiratory rate, oxygen saturation)
  • Physical examination findings (organized by system)
  • Laboratory and imaging results
  • Example:
    • Vitals: T 98.6°F, BP 142/88, HR 92, RR 22, SpO2 91% on room air
    • General: Mild respiratory distress
    • Cardiovascular: Regular rhythm, no murmurs
    • Pulmonary: Bilateral crackles at bases
    • Extremities: 2+ pitting edema bilaterally
A - Assessment
  • Clinical impression or diagnosis
  • Differential diagnosis
  • Severity and stability
  • Progress toward treatment goals
  • Example:
    • "1. Acute decompensated heart failure, NYHA Class III
      1. Hypertension, poorly controlled
      1. Chronic kidney disease, stage 3"
P - Plan
  • Diagnostic plan (further testing)
  • Therapeutic plan (medications, procedures)
  • Patient education and counseling
  • Follow-up arrangements
  • Example:
    • "Diagnostics: BNP, chest X-ray, echocardiogram
    • Therapeutics: Increase furosemide to 40 mg PO BID, continue lisinopril 10 mg daily, strict fluid restriction to 1.5 L/day
    • Education: Signs of worsening heart failure, daily weights
    • Follow-up: Cardiology appointment in 1 week, call if weight gain >2 lbs in 1 day"
Documentation Tips:
  • Be concise but complete
  • Use standard medical abbreviations
  • Document time of encounter
  • Sign and date all notes
  • Avoid speculation or judgment
  • Document medical necessity for billing
  • Include patient's response to treatment
For SOAP note templates and examples, see
assets/soap_note_template.md
.
SOAP记录是临床实践中最常用的病程记录格式。
结构:
S - 主观信息
  • 患者报告的症状和担忧
  • 现病史(HPI)
  • 与就诊相关的系统回顾(ROS)
  • 患者原话(必要时使用引号)
  • 示例:“患者诉过去3天呼吸困难加重,尤其是活动时。否认胸痛、发热或咳嗽。”
O - 客观信息
  • 可测量的临床发现
  • 生命体征(体温、血压、心率、呼吸频率、血氧饱和度)
  • 体格检查结果(按系统组织)
  • 实验室和影像结果
  • 示例:
    • 生命体征:T 98.6°F,BP 142/88,HR 92,RR 22,SpO2 91%(室内空气)
    • 一般情况:轻度呼吸窘迫
    • 心血管:心律齐,无杂音
    • 肺部:双肺底湿啰音
    • 四肢:双下肢2+凹陷性水肿
A - 评估
  • 临床印象或诊断
  • 鉴别诊断
  • 严重程度和稳定性
  • 治疗目标的进展
  • 示例:
    • “1. 急性失代偿性心力衰竭,NYHA III级
      1. 高血压,控制不佳
      1. 慢性肾脏病,3期”
P - 计划
  • 诊断计划(进一步检查)
  • 治疗计划(药物、操作)
  • 患者教育和咨询
  • 随访安排
  • 示例:
    • “诊断:BNP、胸部X线、超声心动图
    • 治疗:将呋塞米增加至40mg口服每日2次,继续赖诺普利10mg每日1次,严格限液至1.5L/天
    • 教育:心力衰竭恶化的体征,每日称重
    • 随访:1周后心内科就诊,如1天内体重增加>2磅请致电”
文档记录技巧:
  • 简洁但完整
  • 使用标准医学缩写
  • 记录诊疗时间
  • 所有记录均需签名和日期
  • 避免猜测或主观判断
  • 记录计费所需的医疗必要性
  • 记录患者对治疗的反应
有关SOAP记录模板和示例,请参阅
assets/soap_note_template.md

History and Physical (H&P)

病史与体格检查(H&P)

The H&P is a comprehensive assessment performed at admission or initial encounter.
Components:
1. Chief Complaint (CC)
  • Brief statement of why patient is seeking care
  • Use patient's own words
  • Example: "Chest pain for 2 hours"
2. History of Present Illness (HPI)
  • Detailed chronological narrative of current problem
  • Use OPQRST mnemonic for pain:
    • Onset: When did it start?
    • Provocation/Palliation: What makes it better or worse?
    • Quality: What does it feel like?
    • Region/Radiation: Where is it? Does it spread?
    • Severity: How bad is it (0-10 scale)?
    • Timing: Constant or intermittent? Duration?
  • Associated symptoms
  • Prior evaluations or treatments
3. Past Medical History (PMH)
  • Chronic medical conditions
  • Previous hospitalizations
  • Surgeries and procedures
  • Example: "Hypertension (diagnosed 2015), type 2 diabetes mellitus (diagnosed 2018), prior appendectomy (2010)"
4. Medications
  • Current medications with doses and frequencies
  • Over-the-counter medications
  • Herbal supplements
  • Allergies and reactions
5. Allergies
  • Drug allergies with type of reaction
  • Food allergies
  • Environmental allergies
  • Example: "Penicillin (rash), shellfish (anaphylaxis)"
6. Family History (FH)
  • Medical conditions in first-degree relatives
  • Age and cause of death of parents
  • Hereditary conditions
  • Example: "Father with coronary artery disease (MI at age 55), mother with breast cancer (diagnosed age 62)"
7. Social History (SH)
  • Tobacco use (pack-years)
  • Alcohol use (drinks per week)
  • Illicit drug use
  • Occupation
  • Living situation
  • Sexual history if relevant
  • Example: "Former smoker, quit 5 years ago (20 pack-year history). Occasional alcohol (2-3 drinks/week). Works as accountant. Lives with spouse."
8. Review of Systems (ROS)
  • Systematic review of symptoms by organ system
  • Typically 10-14 systems
  • Pertinent positives and negatives
  • Systems: Constitutional, Eyes, ENT, Cardiovascular, Respiratory, GI, GU, Musculoskeletal, Skin, Neurological, Psychiatric, Endocrine, Hematologic/Lymphatic, Allergic/Immunologic
9. Physical Examination
  • Vital signs
  • General appearance
  • Systematic examination by organ system
  • HEENT, Neck, Cardiovascular, Pulmonary, Abdomen, Extremities, Neurological, Skin
  • Use standard terminology and abbreviations
10. Assessment and Plan
  • Problem list with assessment and plan for each
  • Numbered list format
  • Diagnostic and therapeutic plans
  • Disposition (admit, discharge, transfer)
For H&P templates, see
assets/history_physical_template.md
.
H&P是入院或首次诊疗时进行的综合性评估。
组成部分:
1. 主诉(CC)
  • 患者就诊原因的简要陈述
  • 使用患者原话
  • 示例:“胸痛2小时”
2. 现病史(HPI)
  • 当前问题的详细 chronological 叙述
  • 对于疼痛,使用OPQRST记忆法:
    • 起病:何时开始?
    • 诱因/缓解因素:什么会使其好转或恶化?
    • 性质:感觉如何?
    • 部位/放射:在哪里?是否放射?
    • 严重程度:有多严重(0-10分)?
    • 时间:持续性还是间歇性?持续多久?
  • 伴随症状
  • 既往评估或治疗
3. 既往病史(PMH)
  • 慢性疾病
  • 既往住院史
  • 手术和操作史
  • 示例:“高血压(2015年诊断),2型糖尿病(2018年诊断),既往阑尾切除术(2010年)”
4. 药物
  • 当前用药(剂量和频率)
  • 非处方药物
  • 草药补充剂
  • 过敏史和反应
5. 过敏史
  • 药物过敏及反应类型
  • 食物过敏
  • 环境过敏
  • 示例:“青霉素(皮疹),贝类(过敏反应)”
6. 家族史(FH)
  • 一级亲属的疾病
  • 父母的年龄和死因
  • 遗传性疾病
  • 示例:“父亲患有冠状动脉疾病(55岁时心梗),母亲患有乳腺癌(62岁诊断)”
7. 社会史(SH)
  • 吸烟史(包年)
  • 饮酒史(每周饮酒量)
  • 非法药物使用
  • 职业
  • 居住情况
  • 如相关,性生活史
  • 示例:“曾吸烟者,5年前戒烟(20包年)。偶尔饮酒(2-3杯/周)。会计职业。与配偶同住。”
8. 系统回顾(ROS)
  • 按器官系统的系统性症状回顾
  • 通常10-14个系统
  • 相关阳性和阴性发现
  • 系统:全身、眼、耳鼻喉、心血管、呼吸、消化、泌尿、肌肉骨骼、皮肤、神经、精神、内分泌、血液/淋巴、过敏/免疫
9. 体格检查
  • 生命体征
  • 一般外观
  • 按器官系统的系统性检查
  • 头眼耳鼻喉、颈部、心血管、肺部、腹部、四肢、神经、皮肤
  • 使用标准术语和缩写
10. 评估与计划
  • 问题列表,每个问题对应评估和计划
  • 编号列表格式
  • 诊断和治疗计划
  • 处置(入院、出院、转院)
有关H&P模板,请参阅
assets/history_physical_template.md

Discharge Summaries

出院小结

Discharge summaries document the hospital stay and communicate care plan to outpatient providers.
Required Elements:
1. Patient Identification
  • Name, date of birth, medical record number
  • Admission and discharge dates
  • Attending physician
  • Admitting and discharge diagnoses
2. Reason for Hospitalization
  • Brief description of presenting problem
  • Chief complaint
3. Hospital Course
  • Chronological narrative of key events
  • Significant findings and procedures
  • Response to treatment
  • Complications
  • Consultations obtained
  • Organized by problem or chronologically
4. Discharge Diagnoses
  • Primary diagnosis
  • Secondary diagnoses
  • Complications
  • Comorbidities
5. Procedures Performed
  • Surgeries
  • Invasive procedures
  • Diagnostic procedures
6. Discharge Medications
  • Complete medication list with instructions
  • Changes from admission medications
  • New medications with indications
7. Discharge Condition
  • Stable, improved, unchanged, expired
  • Functional status
  • Mental status
8. Discharge Disposition
  • Home, skilled nursing facility, rehabilitation, hospice
  • With or without services
9. Follow-up Plans
  • Appointments scheduled
  • Recommended follow-up timing
  • Pending tests or studies
  • Referrals
10. Patient Instructions
  • Activity restrictions
  • Dietary restrictions
  • Wound care
  • Warning signs to seek care
  • Medication instructions
Best Practices:
  • Complete within 24-48 hours of discharge
  • Use clear language for outpatient providers
  • Highlight important pending results
  • Document code status discussions
  • Include patient education provided
For discharge summary templates, see
assets/discharge_summary_template.md
.
出院小结记录住院过程,并向门诊医师传达护理计划。
必填要素:
1. 患者识别信息
  • 姓名、出生日期、病历号
  • 入院和出院日期
  • 主管医师
  • 入院和出院诊断
2. 住院原因
  • 就诊问题的简要描述
  • 主诉
3. 住院经过
  • 关键事件的 chronological 叙述
  • 重要发现和操作
  • 治疗反应
  • 并发症
  • 会诊情况
  • 按问题或时间顺序组织
4. 出院诊断
  • 主要诊断
  • 次要诊断
  • 并发症
  • 合并症
5. 完成的操作
  • 手术
  • 有创操作
  • 诊断操作
6. 出院药物
  • 完整药物列表及使用说明
  • 与入院药物的变化
  • 新药物及适应症
7. 出院状态
  • 稳定、改善、无变化、死亡
  • 功能状态
  • 精神状态
8. 出院去向
  • 家中、专业护理机构、康复机构、临终关怀
  • 有无服务支持
9. 随访计划
  • 已预约的就诊
  • 建议的随访时间
  • 待完成的检查或研究
  • 转诊
10. 患者须知
  • 活动限制
  • 饮食限制
  • 伤口护理
  • 需就医的警示症状
  • 药物使用说明
最佳实践:
  • 出院后24-48小时内完成
  • 使用门诊医师易懂的清晰语言
  • 突出重要的待出结果
  • 记录抢救状态讨论
  • 记录提供的患者教育
有关出院小结模板,请参阅
assets/discharge_summary_template.md

Regulatory Compliance and Privacy

监管合规与隐私

HIPAA Compliance

HIPAA合规

The Health Insurance Portability and Accountability Act (HIPAA) mandates protection of patient health information.
Key Requirements:
  • Minimum necessary disclosure
  • Patient authorization for use beyond treatment/payment/operations
  • Secure storage and transmission
  • Audit trails for electronic records
  • Breach notification procedures
De-identification Methods:
  1. Safe Harbor Method: Remove 18 identifiers
  2. Expert Determination: Statistical method confirming low re-identification risk
Business Associate Agreements: Required when PHI is shared with third parties for services
For detailed HIPAA guidance, see
references/regulatory_compliance.md
.
健康保险流通与责任法案(HIPAA)要求保护患者健康信息。
关键要求:
  • 最小必要披露
  • 超出治疗/付费/运营用途时需获得患者授权
  • 安全存储和传输
  • 电子记录的审计追踪
  • breach通知流程
去标识化方法:
  1. 安全港法:移除18项标识符
  2. 专家判定:确认再识别风险低的统计方法
业务关联协议: 当与第三方共享PHI以获取服务时,需签订该协议
有关HIPAA的详细指南,请参阅
references/regulatory_compliance.md

FDA Regulations

FDA法规

Clinical trial documentation must comply with FDA regulations:
  • 21 CFR Part 11 (Electronic Records and Signatures)
  • 21 CFR Part 50 (Informed Consent)
  • 21 CFR Part 56 (IRB Standards)
  • 21 CFR Part 312 (IND Regulations)
临床试验文档必须符合FDA法规:
  • 21 CFR Part 11(电子记录和签名)
  • 21 CFR Part 50(知情同意)
  • 21 CFR Part 56(IRB标准)
  • 21 CFR Part 312(IND法规)

ICH-GCP Guidelines

ICH-GCP指南

Good Clinical Practice (GCP) guidelines ensure quality and ethical standards in clinical trials:
  • Protocol adherence
  • Informed consent documentation
  • Source document requirements
  • Audit trails and data integrity
  • Investigator responsibilities
For ICH-GCP compliance, see
references/regulatory_compliance.md
.
良好临床实践(GCP)指南确保临床试验的质量和伦理标准:
  • 方案依从性
  • 知情同意文档
  • 源文件要求
  • 审计追踪和数据完整性
  • 研究者职责
有关ICH-GCP合规性,请参阅
references/regulatory_compliance.md

Medical Terminology and Standards

医学术语与标准

Standardized Nomenclature

标准化命名

SNOMED CT (Systematized Nomenclature of Medicine - Clinical Terms)
  • Comprehensive clinical terminology
  • Used for electronic health records
  • Enables semantic interoperability
LOINC (Logical Observation Identifiers Names and Codes)
  • Standard for laboratory and clinical observations
  • Facilitates data exchange and reporting
ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification)
  • Diagnosis coding for billing and epidemiology
  • Required for reimbursement
CPT (Current Procedural Terminology)
  • Procedure coding for billing
  • Maintained by AMA
SNOMED CT(系统化医学术语集-临床术语)
  • 综合性临床术语
  • 用于电子健康记录
  • 实现语义互操作性
LOINC(逻辑观察标识符名称与代码)
  • 实验室和临床观察的标准
  • 促进数据交换和报告
ICD-10-CM(国际疾病分类第10版临床修订本)
  • 用于计费和流行病学的诊断编码
  • 报销必需
CPT(当前操作术语)
  • 用于计费的操作编码
  • 由AMA维护

Abbreviation Standards

缩写标准

Acceptable Abbreviations: Use standard abbreviations to improve efficiency while maintaining clarity.
Do Not Use List (Joint Commission):
  • U (unit) - write "unit"
  • IU (international unit) - write "international unit"
  • QD, QOD (daily, every other day) - write "daily" or "every other day"
  • Trailing zero (X.0 mg) - never use after decimal
  • Lack of leading zero (.X mg) - always use before decimal (0.X mg)
  • MS, MSO4, MgSO4 - write "morphine sulfate" or "magnesium sulfate"
For comprehensive terminology standards, see
references/medical_terminology.md
.
可接受的缩写: 使用标准缩写以提高效率,同时保持清晰。
禁用列表(联合委员会):
  • U(单位) - 写“单位”
  • IU(国际单位) - 写“国际单位”
  • QD、QOD(每日、隔日) - 写“每日”或“隔日”
  • 末尾零(X.0 mg) - 小数点后绝不使用
  • 缺少前导零(.X mg) - 小数点前必须使用(0.X mg)
  • MS、MSO4、MgSO4 - 写“硫酸吗啡”或“硫酸镁”
有关全面的术语标准,请参阅
references/medical_terminology.md

Quality Assurance and Validation

质量保证与验证

Documentation Quality Principles

文档质量原则

Completeness:
  • All required elements present
  • No missing data fields
  • Comprehensive patient information
Accuracy:
  • Factually correct information
  • Verified data sources
  • Appropriate clinical reasoning
Timeliness:
  • Documented contemporaneously or shortly after encounter
  • Time-sensitive reports prioritized
  • Regulatory deadlines met
Clarity:
  • Clear and unambiguous language
  • Organized logical structure
  • Appropriate use of medical terminology
Compliance:
  • Regulatory requirements met
  • Privacy protections in place
  • Institutional policies followed
完整性:
  • 所有必填要素齐全
  • 无缺失数据字段
  • 全面的患者信息
准确性:
  • 信息真实正确
  • 数据来源已验证
  • 临床推理恰当
及时性:
  • 诊疗后即时或尽快记录
  • 优先处理时间敏感的报告
  • 满足监管截止日期
清晰性:
  • 语言清晰明确
  • 逻辑结构有条理
  • 恰当使用医学术语
合规性:
  • 满足监管要求
  • 落实隐私保护
  • 遵循机构政策

Validation Checklists

验证清单

For each report type, use validation checklists to ensure quality:
  • Case report CARE checklist
  • Diagnostic report completeness
  • SAE report regulatory compliance
  • Clinical documentation billing requirements
Validation scripts are available in the
scripts/
directory.
对于每种报告类型,使用验证清单确保质量:
  • 病例报告CARE清单
  • 诊断报告完整性清单
  • SAE报告合规性清单
  • 临床文档计费要求清单
验证脚本位于
scripts/
目录中。

Data Presentation in Clinical Reports

临床报告中的数据呈现

Tables and Figures

表格和图

Tables for Clinical Data:
  • Demographic and baseline characteristics
  • Adverse events summary
  • Laboratory values over time
  • Efficacy outcomes
Table Design Principles:
  • Clear column headers with units
  • Footnotes for abbreviations and statistical notes
  • Consistent formatting
  • Appropriate precision (significant figures)
Figures for Clinical Data:
  • Kaplan-Meier survival curves
  • Forest plots for subgroup analyses
  • Patient flow diagrams (CONSORT)
  • Timeline figures for case reports
  • Before-and-after images
Image Guidelines:
  • High resolution (300 dpi minimum)
  • Appropriate scale bars
  • Annotations for key features
  • De-identified (no patient identifiers visible)
  • Informed consent for recognizable images
For data presentation standards, see
references/data_presentation.md
.
临床数据表格:
  • 人口统计学和基线特征
  • 不良事件汇总
  • 实验室值随时间变化
  • 疗效结局
表格设计原则:
  • 清晰的列标题(含单位)
  • 缩写和统计说明的脚注
  • 格式一致
  • 恰当的精度(有效数字)
临床数据图:
  • Kaplan-Meier生存曲线
  • 亚组分析的森林图
  • 患者流程图(CONSORT)
  • 病例报告的时间线图
  • 前后对比影像
影像指南:
  • 高分辨率(最低300dpi)
  • 恰当的比例尺
  • 关键特征的标注
  • 去标识化(无患者可见标识符)
  • 可识别影像的知情同意
有关数据呈现标准,请参阅
references/data_presentation.md

Integration with Other Skills

与其他技能的整合

This clinical reports skill integrates with:
  • Scientific Writing: For clear, professional medical writing
  • Peer Review: For quality assessment of case reports
  • Citation Management: For literature references in case reports
  • Research Grants: For clinical trial protocol development
  • Literature Review: For background sections in case reports
本临床报告技能可与以下技能整合:
  • 科学写作:用于清晰、专业的医学写作
  • 同行评审:用于病例报告的质量评估
  • 引用管理:用于病例报告中的文献引用
  • 研究基金:用于临床试验方案开发
  • 文献综述:用于病例报告中的背景部分

Workflow for Clinical Report Writing

临床报告撰写工作流

Case Report Workflow

病例报告工作流

Phase 1: Case Identification and Consent (Week 1)
  • Identify novel or educational case
  • Obtain patient informed consent
  • De-identify patient information
  • Collect clinical data and images
Phase 2: Literature Review (Week 1-2)
  • Search for similar cases
  • Review relevant pathophysiology
  • Identify knowledge gaps
  • Determine novelty and significance
Phase 3: Drafting (Week 2-3)
  • Write structured outline following CARE guidelines
  • Draft all sections (abstract through discussion)
  • Create timeline and figures
  • Format references
Phase 4: Internal Review (Week 3-4)
  • Co-author review
  • Attending physician review
  • Institutional review if required
  • Patient review of de-identified draft
Phase 5: Journal Selection and Submission (Week 4-5)
  • Select appropriate journal
  • Format per journal guidelines
  • Prepare cover letter
  • Submit manuscript
Phase 6: Revision (Variable)
  • Respond to peer reviewer comments
  • Revise manuscript
  • Resubmit
阶段1:病例识别与知情同意(第1周)
  • 识别新颖或具有教育意义的病例
  • 获取患者知情同意
  • 对患者信息进行去标识化
  • 收集临床数据和影像
阶段2:文献综述(第1-2周)
  • 搜索类似病例
  • 回顾相关病理生理学
  • 识别知识空白
  • 确定新颖性和重要性
阶段3:起草(第2-3周)
  • 遵循CARE指南撰写结构化大纲
  • 起草所有章节(摘要至讨论)
  • 创建时间线和图
  • 格式化参考文献
阶段4:内部评审(第3-4周)
  • 共同作者评审
  • 主管医师评审
  • 如需要,机构评审
  • 患者对去标识化草稿的评审
阶段5:期刊选择与投稿(第4-5周)
  • 选择合适的期刊
  • 按期刊指南格式化
  • 准备投稿信
  • 提交手稿
阶段6:修订(时间可变)
  • 回复同行评审意见
  • 修改手稿
  • 重新提交

Diagnostic Report Workflow

诊断报告工作流

Real-time Workflow:
  • Review clinical indication and prior studies
  • Interpret imaging, pathology, or laboratory findings
  • Dictate or type report using structured format
  • Peer review for complex cases
  • Final sign-out and distribution
  • Critical value notification if applicable
Turnaround Time Benchmarks:
  • STAT reports: <1 hour
  • Routine reports: 24-48 hours
  • Complex cases: 2-5 days
  • Pending additional studies: documented delay
实时工作流:
  • 回顾临床指征和既往研究
  • 解读影像、病理或实验室发现
  • 使用结构化格式口述或撰写报告
  • 复杂病例的同行评审
  • 最终签出和分发
  • 如适用,危急值通知
周转时间基准:
  • STAT报告:<1小时
  • 常规报告:24-48小时
  • 复杂病例:2-5天
  • 待进一步检查:记录延迟原因

Clinical Trial Report Workflow

临床试验报告工作流

SAE Report: 24 hours to 15 days
  • Event identified by site
  • Initial assessment and documentation
  • Causality and expectedness determination
  • Report completion and review
  • Submission to sponsor, IRB, FDA (as required)
  • Follow-up reporting until resolution
CSR: 6-12 months post-study completion
  • Database lock and data cleaning
  • Statistical analysis per SAP
  • Drafting by medical writer
  • Review by biostatistician and clinical team
  • Quality control review
  • Final approval and regulatory submission
SAE报告:24小时至15天
  • 研究中心识别事件
  • 初步评估和记录
  • 因果关系和预期性判定
  • 报告完成和评审
  • 提交给申办方、IRB、FDA(如要求)
  • 随访报告直至事件缓解
CSR:研究完成后6-12个月
  • 数据库锁定和数据清理
  • 按SAP进行统计分析
  • 医学撰稿人起草
  • 生物统计师和临床团队评审
  • 质量控制评审
  • 最终批准和监管申报

Resources

资源

This skill includes comprehensive reference files and templates:
本技能包含全面的参考文件和模板:

Reference Files

参考文件

  • references/case_report_guidelines.md
    - CARE guidelines, journal requirements, writing tips
  • references/diagnostic_reports_standards.md
    - ACR, CAP, laboratory reporting standards
  • references/clinical_trial_reporting.md
    - ICH-E3, CONSORT, SAE reporting, CSR structure
  • references/patient_documentation.md
    - SOAP notes, H&P, discharge summaries, coding
  • references/regulatory_compliance.md
    - HIPAA, 21 CFR Part 11, ICH-GCP, FDA requirements
  • references/medical_terminology.md
    - SNOMED, LOINC, ICD-10, abbreviations, nomenclature
  • references/data_presentation.md
    - Tables, figures, safety data, CONSORT diagrams
  • references/peer_review_standards.md
    - Review criteria for clinical manuscripts
  • references/case_report_guidelines.md
    - CARE指南、期刊要求、写作技巧
  • references/diagnostic_reports_standards.md
    - ACR、CAP、实验室报告标准
  • references/clinical_trial_reporting.md
    - ICH-E3、CONSORT、SAE报告、CSR结构
  • references/patient_documentation.md
    - SOAP记录、H&P、出院小结、编码
  • references/regulatory_compliance.md
    - HIPAA、21 CFR Part 11、ICH-GCP、FDA要求
  • references/medical_terminology.md
    - SNOMED、LOINC、ICD-10、缩写、命名
  • references/data_presentation.md
    - 表格、图、安全性数据、CONSORT图
  • references/peer_review_standards.md
    - 临床手稿的评审标准

Template Assets

模板资源

  • assets/case_report_template.md
    - Structured case report following CARE guidelines
  • assets/radiology_report_template.md
    - Standard radiology report format
  • assets/pathology_report_template.md
    - Surgical pathology report with synoptic elements
  • assets/lab_report_template.md
    - Clinical laboratory report format
  • assets/clinical_trial_sae_template.md
    - Serious adverse event report form
  • assets/clinical_trial_csr_template.md
    - Clinical study report outline per ICH-E3
  • assets/soap_note_template.md
    - SOAP progress note format
  • assets/history_physical_template.md
    - Comprehensive H&P template
  • assets/discharge_summary_template.md
    - Hospital discharge summary
  • assets/consult_note_template.md
    - Consultation note format
  • assets/quality_checklist.md
    - Quality assurance checklist for all report types
  • assets/hipaa_compliance_checklist.md
    - Privacy and de-identification checklist
  • assets/case_report_template.md
    - 遵循CARE指南的结构化病例报告模板
  • assets/radiology_report_template.md
    - 标准放射报告格式
  • assets/pathology_report_template.md
    - 包含概要要素的外科病理报告模板
  • assets/lab_report_template.md
    - 临床实验室报告格式
  • assets/clinical_trial_sae_template.md
    - 严重不良事件报告表
  • assets/clinical_trial_csr_template.md
    - 符合ICH-E3的临床研究报告大纲
  • assets/soap_note_template.md
    - SOAP病程记录格式
  • assets/history_physical_template.md
    - 综合性H&P模板
  • assets/discharge_summary_template.md
    - 住院出院小结模板
  • assets/consult_note_template.md
    - 会诊记录格式
  • assets/quality_checklist.md
    - 所有报告类型的质量保证清单
  • assets/hipaa_compliance_checklist.md
    - 隐私和去标识化清单

Automation Scripts

自动化脚本

  • scripts/validate_case_report.py
    - Check CARE guideline compliance and completeness
  • scripts/validate_trial_report.py
    - Verify ICH-E3 structure and required elements
  • scripts/check_deidentification.py
    - Scan for 18 HIPAA identifiers in text
  • scripts/format_adverse_events.py
    - Generate AE summary tables from data
  • scripts/generate_report_template.py
    - Interactive template selection and generation
  • scripts/extract_clinical_data.py
    - Parse structured data from clinical reports
  • scripts/compliance_checker.py
    - Verify regulatory compliance requirements
  • scripts/terminology_validator.py
    - Validate medical terminology and coding
Load these resources as needed when working on specific clinical reports.
  • scripts/validate_case_report.py
    - 检查CARE指南合规性和完整性
  • scripts/validate_trial_report.py
    - 验证ICH-E3结构和必填要素
  • scripts/check_deidentification.py
    - 扫描文本中的18项HIPAA标识符
  • scripts/format_adverse_events.py
    - 从数据生成AE汇总表
  • scripts/generate_report_template.py
    - 交互式模板选择和生成
  • scripts/extract_clinical_data.py
    - 从临床报告中解析结构化数据
  • scripts/compliance_checker.py
    - 验证监管合规要求
  • scripts/terminology_validator.py
    - 验证医学术语和编码
在处理特定临床报告时,可根据需要加载这些资源。

Common Pitfalls to Avoid

需避免的常见陷阱

Case Reports

病例报告

  • Privacy violations: Inadequate de-identification or missing consent
  • Lack of novelty: Reporting common or well-documented cases
  • Insufficient detail: Missing key clinical information
  • Poor literature review: Failure to contextualize within existing knowledge
  • Overgeneralization: Drawing broad conclusions from single case
  • 隐私违规:去标识化不足或缺失知情同意
  • 缺乏新颖性:报告常见或已充分记录的病例
  • 细节不足:缺少关键临床信息
  • 文献综述质量差:未能结合现有知识进行 contextualize
  • 过度泛化:从单个病例得出广泛结论

Diagnostic Reports

诊断报告

  • Vague language: Using ambiguous terms like "unremarkable" without specifics
  • Incomplete comparison: Not reviewing prior imaging
  • Missing clinical correlation: Failing to answer clinical question
  • Technical jargon: Overuse of terminology without explanation
  • Delayed critical value notification: Not communicating urgent findings
  • 语言模糊:使用“未见异常”等模糊术语而无具体内容
  • 对比不完整:未回顾既往影像
  • 缺乏临床关联:未解答临床问题
  • 技术术语过度使用:过度使用术语而未解释
  • 危急值通知延迟:未传达紧急发现

Clinical Trial Reports

临床试验报告

  • Late reporting: Missing regulatory deadlines for SAE reporting
  • Incomplete causality: Inadequate causality assessment
  • Data inconsistencies: Discrepancies between data sources
  • Protocol deviations: Unreported or inadequately documented deviations
  • Selective reporting: Omitting negative or unfavorable results
  • 报告延迟:错过SAE报告的监管截止日期
  • 因果关系评估不完整:因果关系评估不足
  • 数据不一致:数据源之间存在差异
  • 方案偏离:未报告或记录不足的偏离
  • 选择性报告:遗漏阴性或不利结果

Patient Documentation

患者文档

  • Illegibility: Poor handwriting in paper records
  • Copy-forward errors: Propagating outdated information
  • Insufficient detail: Vague or incomplete documentation affecting billing
  • Lack of medical necessity: Not documenting indication for services
  • Missing signatures: Unsigned or undated notes
  • 字迹潦草:纸质记录中的手写体难以辨认
  • 复制粘贴错误:传播过时信息
  • 细节不足:模糊或不完整的文档影响计费
  • 缺乏医疗必要性:未记录服务指征
  • 缺少签名:未签名或未标注日期的记录

Final Checklist

最终检查清单

Before finalizing any clinical report, verify:
  • All required sections complete
  • Patient privacy protected (HIPAA compliance)
  • Informed consent obtained (if applicable)
  • Accurate and verified clinical data
  • Appropriate medical terminology and coding
  • Clear, professional language
  • Proper formatting per guidelines
  • References cited appropriately
  • Figures and tables labeled correctly
  • Spell-checked and proofread
  • Regulatory requirements met
  • Institutional policies followed
  • Signatures and dates present
  • Quality assurance review completed

Final Note: Clinical report writing requires attention to detail, medical accuracy, regulatory compliance, and clear communication. Whether documenting patient care, reporting research findings, or communicating diagnostic results, the quality of clinical reports directly impacts patient safety, healthcare delivery, and medical knowledge advancement. Always prioritize accuracy, privacy, and professionalism in all clinical documentation.
在最终确定任何临床报告前,验证以下内容:
  • 所有必填章节完整
  • 患者隐私受保护(HIPAA合规)
  • 已获得知情同意(如适用)
  • 临床数据准确且已验证
  • 使用恰当的医学术语和编码
  • 语言清晰、专业
  • 格式符合指南要求
  • 参考文献引用恰当
  • 图和表格标注正确
  • 已拼写检查和校对
  • 满足监管要求
  • 遵循机构政策
  • 包含签名和日期
  • 已完成质量保证评审

最终提示:临床报告撰写需要注重细节、医学准确性、监管合规性和清晰沟通。无论是记录患者护理、报告研究结果还是传达诊断结果,临床报告的质量直接影响患者安全、医疗服务提供和医学知识的进步。在所有临床文档中,始终优先考虑准确性、隐私性和专业性。